Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 3 |
2022 | 3 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Exploiting Canonical TGFβ Signaling in Cancer Treatment.
Mol Cancer Ther. 2022 Jan;21(1):16-24. doi: 10.1158/1535-7163.MCT-20-0891. Epub 2021 Oct 20.
Mol Cancer Ther. 2022.
PMID: 34670783
Free PMC article.
Review.
A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials.
Whiteaker JR, Zhao L, Schoenherr RM, Huang D, Lundeen RA, Voytovich U, Kennedy JJ, Ivey RG, Lin C, Murillo OD, Lorentzen TD, Colantonio S, Caceres TW, Roberts RR, Knotts JG, Reading JJ, Perry CD, Richardson CW, Garcia-Buntley SS, Bocik W, Hewitt SM, Chowdhury S, Vandermeer J, Smith SD, Gopal AK, Ramchurren N, Fling SP, Wang P, Paulovich AG.
Whiteaker JR, et al.
Front Oncol. 2023 May 2;13:1168710. doi: 10.3389/fonc.2023.1168710. eCollection 2023.
Front Oncol. 2023.
PMID: 37205196
Free PMC article.
Item in Clipboard
Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy.
Barcellos-Hoff MH, Gulley JL.
Barcellos-Hoff MH, et al.
Clin Cancer Res. 2023 Jun 1;29(11):2025-2033. doi: 10.1158/1078-0432.CCR-21-3750.
Clin Cancer Res. 2023.
PMID: 36598437
Free PMC article.
Item in Clipboard
Mammary Tumor-Derived Transplants as Breast Cancer Models to Evaluate Tumor-Immune Interactions and Therapeutic Responses.
Moore J, Ma L, Lazar AA, Barcellos-Hoff MH.
Moore J, et al.
Cancer Res. 2022 Feb 1;82(3):365-376. doi: 10.1158/0008-5472.CAN-21-0253. Epub 2021 Dec 13.
Cancer Res. 2022.
PMID: 34903599
Free PMC article.
Item in Clipboard
Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.
Guix I, Liu Q, Pujana MA, Ha P, Piulats J, Linares I, Guedea F, Mao JH, Lazar A, Chapman J, Yom SS, Ashworth A, Barcellos-Hoff MH.
Guix I, et al.
Clin Cancer Res. 2022 Apr 1;28(7):1372-1382. doi: 10.1158/1078-0432.CCR-21-2846.
Clin Cancer Res. 2022.
PMID: 35022323
Free PMC article.
Item in Clipboard
Loss of TGFβ signaling increases alternative end-joining DNA repair that sensitizes to genotoxic therapies across cancer types.
Liu Q, Palomero L, Moore J, Guix I, Espín R, Aytés A, Mao JH, Paulovich AG, Whiteaker JR, Ivey RG, Iliakis G, Luo D, Chalmers AJ, Murnane J, Pujana MA, Barcellos-Hoff MH.
Liu Q, et al.
Sci Transl Med. 2021 Feb 10;13(580):eabc4465. doi: 10.1126/scitranslmed.abc4465.
Sci Transl Med. 2021.
PMID: 33568520
Free PMC article.
Item in Clipboard
Cite
Cite